BRS3(FM3) - Inflammation Resolution Capacity
1. Definition
Functional control point governing active termination of inflammation through pro-resolving lipid mediators rather than simple suppression.
2. Functional Outcome Context
These outcomes describe translational contexts for the FM as an integrated biological capacity. They are not single-mechanism treatment claims. Confidence may increase where multiple child PMs converge on the same functional outcome.
No functional outcome context currently mapped.
3. Intervention Breakdown
Food-State Dominant
4. Functional Role
↑ resolvins/protectins/maresins; ↑ debris clearance; ↓ unresolved inflammation
5. Mechanistic Basis (Integrated FM Narrative)
Inflammation resolution capacity emerges from the coordinated interaction of several primary mechanisms and supporting biological pools.
5.1 Core Primary Mechanisms
-
BRS3-FM3-PM7 — Cytokine Network Modulation Modulation of cytokine signalling tone across IL-6, TNF-a, CRP-linked inflammatory pathways.
-
BRS3-FM3-PM8 — Eicosanoid / SPM Balance Balancing arachidonic-acid-derived inflammatory mediators against EPA/DHA-derived specialized pro-resolving mediators.
5.2 Supporting Biological Pools (Key Constraints)
- BRS3(KC3) — Essential Fatty Acid Balance Provides the shared structural and signalling lipid pool required for inflammatory mediator production, membrane function, and inflammation-resolution pathways.
5.3 Integrated Functional Narrative
Together, these PMs operationalise BRS3(FM3) as coordinated inflammation resolution capacity.
At the integrated FM level, this is distinct from simple suppression: resolution requires the right lipid substrate context to terminate inflammatory activity, shift mediator balance, and allow cytokine pressure to fall. Lipid peroxidation control from BRS3-FM2-PM5 remains supportive here by helping preserve the integrity of the lipid environment on which resolution depends [1][2][3].
5.4 Functional Failure Modes
Inflammation resolution capacity may weaken when essential fatty acid balance declines or when low omega-3 intake.
Low omega-3 intake may reduce BRS3(KC3) — Essential Fatty Acid Balance. Excessive omega-6 dominance may further strain pool availability, low oily fish consumption, poor dietary fatty-acid diversity, while chronic inflammatory load.
These pressures may impair BRS3-FM3-PM7 — Cytokine Network Modulation, and weaken BRS3-FM3-PM8 — Eicosanoid / SPM Balance. At the FM level, this may shift BRS3(FM3) toward reduced inflammation resolution capacity performance.
6. Connected Mechanisms
- BRS3-FM2-PM5 - Lipid Peroxidation Control - supportive membrane-protection context